Kodein Stærk "dak"

Codeine phosphate, the active ingredient in Kodein Stærk "dak", is an opioid analgesic presented as an oral dosage form for oral use. It is employed to relieve moderate pain and to suppress cough in appropriate patients. It is formulated according to EU pharmacopeial specifications and is available only by prescription.

GNH USA supplies Kodein Stærk "dak" as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution.

Kodein Stærk "dak" (codeine phosphate) acts on the central nervous system to provide analgesia and antitussive effects. - Moderate pain: reduces pain intensity in patients with acute or chronic moderate pain. - Acute pain: provides short‑term relief for postoperative or injury‑related pain. - Cough: suppresses the cough reflex in patients with non‑productive cough.

Codeine phosphate may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea: feeling of stomach upset that may lead to vomiting. - Constipation: reduced bowel movements and hard stools. - Drowsiness: increased sleepiness or fatigue. - Dry mouth: reduced salivation causing a parched sensation.

Serious or Rare Side Effects: - Respiratory depression: slowed or shallow breathing that can be life‑threatening. - Severe allergic reaction (anaphylaxis): rash, swelling, difficulty breathing. - Dependence or addiction: compulsive use despite harmful consequences.

When prescribing or dispensing Kodein Stærk "dak", several safety considerations should be observed. - Assess pain level and cough severity: ensure the drug is appropriate for the indicated condition. - Avoid concurrent CNS depressants: do not combine with alcohol, benzodiazepines or other opioids without medical supervision. - Use caution in respiratory disorders: patients with asthma or COPD may be at increased risk of respiratory depression. - Monitor for signs of dependence: watch for cravings, tolerance increase or withdrawal symptoms during prolonged therapy. - Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Codeine phosphate can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - CNS depressants (e.g., benzodiazepines, barbiturates, alcohol): may cause profound sedation and respiratory depression. - MAO inhibitors: can precipitate severe hypertension or serotonin syndrome when combined.

Moderate Interactions (Monitor Closely): - CYP2D6 inhibitors (e.g., fluoxetine, paroxetine): may reduce conversion to morphine and diminish analgesic effect. - Antihistamines (e.g., diphenhydramine): can increase drowsiness and anticholinergic burden. - Diuretics: may enhance the risk of hypotension when combined with opioid‑induced vasodilation.